Depo-SubQ Provera
NDC 0009-4709, medroxyprogesterone acetate, injection, suspension, from Pharmacia & Upjohn Company LLC.
- Product NDC
- 0009-4709
- Status
- Listed
- Labeler
- Pharmacia & Upjohn Company LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021583
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0009-4709 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEDROXYPROGESTERONE ACETATE104 mg/.65mL
Pharmacologic classes
Progesterone Congeners [CS]; Progestin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0009-4709-13 | 00009470913 | 1 SYRINGE in 1 CARTON (0009-4709-13) / .65 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/390087a6-f3c3-4f0b-a930-79acf412f153NADAC price for package 00009470913
GET /v1/drugs/nadac/00009470913
Use it
Look up 0009-4709 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0009-4709 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0009-4709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.